Template:Cryptosporidiosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Cryptosporidiosis (patient information)|Patient Inforamtion]]
[[Cryptosporidiosis (patient information)|Patient Information]]
|-  
|-  
!
!
Line 58: Line 58:
!
!
[[Cryptosporidiosis risk factors|Risk Factors]]
[[Cryptosporidiosis risk factors|Risk Factors]]
|-
!
|- bgcolor="Pink"
!
[[Cryptosporidiosis screening|Screening]]
|-  
|-  
!
!
Line 94: Line 88:
!
!
[[Cryptosporidiosis laboratory tests|Laboratory Findings]]
[[Cryptosporidiosis laboratory tests|Laboratory Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Cryptosporidiosis chest x ray|Chest X Ray]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Cryptosporidiosis CT|CT]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Cryptosporidiosis MRI|MRI]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Cryptosporidiosis echocardiography or ultrasound|Echocardiography or Ultrasound]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Cryptosporidiosis other imaging findings|Other Imaging Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Cryptosporidiosis other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 142: Line 100:
!
!
[[Cryptosporidiosis medical therapy|Medical Therapy]]
[[Cryptosporidiosis medical therapy|Medical Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Cryptosporidiosis surgery|Surgery]]
|-  
|-  
!
!
Line 154: Line 106:
!
!
[[Cryptosporidiosis primary prevention|Primary Prevention]]
[[Cryptosporidiosis primary prevention|Primary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Cryptosporidiosis secondary prevention|Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Cryptosporidiosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Cryptosporidiosis future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  

Revision as of 17:03, 21 November 2012